Report Detail

Request for Sample of this report

Pharma & Healthcare Global Crude Heparin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM3580058
    • |
  • 25 July, 2023
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Crude Heparin market size was valued at USD 3555 million in 2022 and is forecast to a readjusted size of USD 5318.6 million by 2029 with a CAGR of 5.9% during review period.
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Fengrun Biological Technology. The top three players hold a share about 30%. The global crude heparin products are mainly produced in Europe and China. Asia-Pacific is the largest market, has a share about 57%, followed by North America and Europe, with share 21% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 90%.
The Global Info Research report includes an overview of the development of the Crude Heparin industry chain, the market status of UFH (Pig Intestine Mucosa Heparin, Bovine Heparin and Others), LMWH (Pig Intestine Mucosa Heparin, Bovine Heparin and Others), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Crude Heparin.
Regionally, the report analyzes the Crude Heparin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Crude Heparin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Crude Heparin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Crude Heparin industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., Pig Intestine Mucosa Heparin, Bovine Heparin and Others).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Crude Heparin market.
Regional Analysis: The report involves examining the Crude Heparin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Crude Heparin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Crude Heparin:
Company Analysis: Report covers individual Crude Heparin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Crude Heparin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (UFH, LMWH).
Technology Analysis: Report covers specific technologies relevant to Crude Heparin. It assesses the current state, advancements, and potential future developments in Crude Heparin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Crude Heparin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Crude Heparin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Market segment by Application
UFH
LMWH
Major players covered
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Crude Heparin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Crude Heparin, with price, sales, revenue and global market share of Crude Heparin from 2018 to 2023.
Chapter 3, the Crude Heparin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Crude Heparin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Crude Heparin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Crude Heparin.
Chapter 14 and 15, to describe Crude Heparin sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Crude Heparin
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Crude Heparin Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Pig Intestine Mucosa Heparin
    • 1.3.3 Bovine Heparin and Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Crude Heparin Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 UFH
    • 1.4.3 LMWH
  • 1.5 Global Crude Heparin Market Size & Forecast
    • 1.5.1 Global Crude Heparin Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Crude Heparin Sales Quantity (2018-2029)
    • 1.5.3 Global Crude Heparin Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Bioiberica
    • 2.1.1 Bioiberica Details
    • 2.1.2 Bioiberica Major Business
    • 2.1.3 Bioiberica Crude Heparin Product and Services
    • 2.1.4 Bioiberica Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Bioiberica Recent Developments/Updates
  • 2.2 Shenzhen Hepalink
    • 2.2.1 Shenzhen Hepalink Details
    • 2.2.2 Shenzhen Hepalink Major Business
    • 2.2.3 Shenzhen Hepalink Crude Heparin Product and Services
    • 2.2.4 Shenzhen Hepalink Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Shenzhen Hepalink Recent Developments/Updates
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Crude Heparin Product and Services
    • 2.3.4 Sanofi Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Sanofi Recent Developments/Updates
  • 2.4 Nanjing King-friend
    • 2.4.1 Nanjing King-friend Details
    • 2.4.2 Nanjing King-friend Major Business
    • 2.4.3 Nanjing King-friend Crude Heparin Product and Services
    • 2.4.4 Nanjing King-friend Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Nanjing King-friend Recent Developments/Updates
  • 2.5 Fengrun Biological Technology
    • 2.5.1 Fengrun Biological Technology Details
    • 2.5.2 Fengrun Biological Technology Major Business
    • 2.5.3 Fengrun Biological Technology Crude Heparin Product and Services
    • 2.5.4 Fengrun Biological Technology Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Fengrun Biological Technology Recent Developments/Updates
  • 2.6 Aspen Oss
    • 2.6.1 Aspen Oss Details
    • 2.6.2 Aspen Oss Major Business
    • 2.6.3 Aspen Oss Crude Heparin Product and Services
    • 2.6.4 Aspen Oss Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Aspen Oss Recent Developments/Updates
  • 2.7 Hebei Changshan Biochemical
    • 2.7.1 Hebei Changshan Biochemical Details
    • 2.7.2 Hebei Changshan Biochemical Major Business
    • 2.7.3 Hebei Changshan Biochemical Crude Heparin Product and Services
    • 2.7.4 Hebei Changshan Biochemical Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Hebei Changshan Biochemical Recent Developments/Updates
  • 2.8 Changzhou Qianhong
    • 2.8.1 Changzhou Qianhong Details
    • 2.8.2 Changzhou Qianhong Major Business
    • 2.8.3 Changzhou Qianhong Crude Heparin Product and Services
    • 2.8.4 Changzhou Qianhong Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Changzhou Qianhong Recent Developments/Updates
  • 2.9 Hepac (Darling Ingredients)
    • 2.9.1 Hepac (Darling Ingredients) Details
    • 2.9.2 Hepac (Darling Ingredients) Major Business
    • 2.9.3 Hepac (Darling Ingredients) Crude Heparin Product and Services
    • 2.9.4 Hepac (Darling Ingredients) Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Hepac (Darling Ingredients) Recent Developments/Updates
  • 2.10 Huaian MDC Pharmaceutical
    • 2.10.1 Huaian MDC Pharmaceutical Details
    • 2.10.2 Huaian MDC Pharmaceutical Major Business
    • 2.10.3 Huaian MDC Pharmaceutical Crude Heparin Product and Services
    • 2.10.4 Huaian MDC Pharmaceutical Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Huaian MDC Pharmaceutical Recent Developments/Updates
  • 2.11 Yantai Dongcheng Biochemicals
    • 2.11.1 Yantai Dongcheng Biochemicals Details
    • 2.11.2 Yantai Dongcheng Biochemicals Major Business
    • 2.11.3 Yantai Dongcheng Biochemicals Crude Heparin Product and Services
    • 2.11.4 Yantai Dongcheng Biochemicals Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Yantai Dongcheng Biochemicals Recent Developments/Updates

3 Competitive Environment: Crude Heparin by Manufacturer

  • 3.1 Global Crude Heparin Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Crude Heparin Revenue by Manufacturer (2018-2023)
  • 3.3 Global Crude Heparin Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Crude Heparin by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Crude Heparin Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Crude Heparin Manufacturer Market Share in 2022
  • 3.5 Crude Heparin Market: Overall Company Footprint Analysis
    • 3.5.1 Crude Heparin Market: Region Footprint
    • 3.5.2 Crude Heparin Market: Company Product Type Footprint
    • 3.5.3 Crude Heparin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Crude Heparin Market Size by Region
    • 4.1.1 Global Crude Heparin Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Crude Heparin Consumption Value by Region (2018-2029)
    • 4.1.3 Global Crude Heparin Average Price by Region (2018-2029)
  • 4.2 North America Crude Heparin Consumption Value (2018-2029)
  • 4.3 Europe Crude Heparin Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Crude Heparin Consumption Value (2018-2029)
  • 4.5 South America Crude Heparin Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Crude Heparin Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Crude Heparin Sales Quantity by Type (2018-2029)
  • 5.2 Global Crude Heparin Consumption Value by Type (2018-2029)
  • 5.3 Global Crude Heparin Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Crude Heparin Sales Quantity by Application (2018-2029)
  • 6.2 Global Crude Heparin Consumption Value by Application (2018-2029)
  • 6.3 Global Crude Heparin Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Crude Heparin Sales Quantity by Type (2018-2029)
  • 7.2 North America Crude Heparin Sales Quantity by Application (2018-2029)
  • 7.3 North America Crude Heparin Market Size by Country
    • 7.3.1 North America Crude Heparin Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Crude Heparin Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Crude Heparin Sales Quantity by Type (2018-2029)
  • 8.2 Europe Crude Heparin Sales Quantity by Application (2018-2029)
  • 8.3 Europe Crude Heparin Market Size by Country
    • 8.3.1 Europe Crude Heparin Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Crude Heparin Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Crude Heparin Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Crude Heparin Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Crude Heparin Market Size by Region
    • 9.3.1 Asia-Pacific Crude Heparin Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Crude Heparin Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Crude Heparin Sales Quantity by Type (2018-2029)
  • 10.2 South America Crude Heparin Sales Quantity by Application (2018-2029)
  • 10.3 South America Crude Heparin Market Size by Country
    • 10.3.1 South America Crude Heparin Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Crude Heparin Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Crude Heparin Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Crude Heparin Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Crude Heparin Market Size by Country
    • 11.3.1 Middle East & Africa Crude Heparin Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Crude Heparin Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Crude Heparin Market Drivers
  • 12.2 Crude Heparin Market Restraints
  • 12.3 Crude Heparin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Crude Heparin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Crude Heparin
  • 13.3 Crude Heparin Production Process
  • 13.4 Crude Heparin Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Crude Heparin Typical Distributors
  • 14.3 Crude Heparin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Crude Heparin. Industry analysis & Market Report on Crude Heparin is a syndicated market report, published as Global Crude Heparin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Crude Heparin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,777.04
    		4,165.56
    		5,554.08
    		3,250.32
    		4,875.48
    		6,500.64
    		543,819.60
    		815,729.40
    		1,087,639.20
    		290,545.20
    		435,817.80
    		581,090.40
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo